2:2 degree (or international equivalent).
Months of entry
The course covers both antibody and vaccine cancer therapies and explores the immunology of the tumour host interface. In addition, students will learn about intellectual property and how to exploit scientific research in scientific writings, patents and in development of business plans applicable to the biotechnology industry. To gain practical experience in research students will carry out a research project in the field of tumour immunology.
Aims and Objectives:
Acquire a specialised knowledge in tumour immunology with particular reference to monoclonal antibody and cancer vaccines
Develop the critical and analytical power to evaluate scientific literature
Perform a scientific research project
Acquire the ability to communicate scientific results orally and in writing
Learn about business exploitation of cancer therapy
For a more extensive overview, please visit the course page on the University of Nottingham's online prospectus.
Information for international students
English language requirements: IELTS 6.5 (no less than 6.0 in any element), achieved within 2 years prior to admission.
Fees and funding
The Graduate School at The University of Nottingham provides information on internal and external sources of postgraduate funding.
There is also funding information on the Medical School web pages.
For information on funding opportunities for international students, please see the International Office website.
Qualification and course duration
Course contact details
- Postgraduate Enquiries
- +44 (0) 115 951 5559